Search Results 651-660 of 17041 for monoclonal antibody
Hypersensitivity to any monoclonal antibody treatment 7. Any immunological disease which is not adequately controlled, or which requires treatment with ...
... monoclonal antibody and at least 1 steroid. Participant had at least a minimal response (MR) to the anti-CD38 antibody containing regimen and had last dose ...
Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...
These are the findings of a study by Mayo Clinic researchers published in the Wednesday, Jan. 17, issue of the New England Journal of Medicine. Monoclonal ...
To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody ... monoclonal antibody, or Interleukin-2 (IL-2) co ...
The purpose of this study is to evaluate the utility of using anti-HLA antibody titer to measure the effectiveness of antibody lowering therapy (i.e. ...
The purpose of this study is to measure SARS-CoV-2 Spike protein antibody titers in a vaccinated cohort. ... Receipt of any COVID-19-specific monoclonal ...
antibody levels. So when exposed, they could develop disease ... Some of the mutations are making vaccines, plasma, monoclonal antibodies less effective.
... monoclonal antibody (bevacizumab, ramucirumab, or aflibercept), and an anti-PD-1 monoclonal antibody (nivolumab or pembrolizumab) if tumor has deficient ...
About this study. The purpose of this study is to determine the safety profile, maximum tolerable dose (MTD) and cohort expansion of single-agent GBR 1342 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.